FDA Import Refusal 799-7803761-2/21/1 — Glaxosmithkline

Glaxosmithkline — FEI 3003451948

The FDA refused shipment 799-7803761-2/21/1 from Glaxosmithkline (United Kingdom) on Nov 8, 2023. The refused product falls under Drugs and Biologics — SUMATRIPTAN SUCCINATE (ANTIMIGRAINE AGENT). Cited charge: 75 This firm has 5 or more other import refusals on record.